Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials

OBJECTIVE: Analyze tofacitinib efficacy and safety by background methotrexate (MTX) dose in patients with psoriatic arthritis (PsA). METHODS: This post hoc analysis pooled data from two phase III, double-blind trials (OPAL Broaden, NCT01877668; OPAL Beyond, NCT01882439) including patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivitz, Alan J., FitzGerald, Oliver, Nash, Peter, Pang, Shirley, Azevedo, Valderilio F., Wang, Cunshan, Takiya, Liza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782818/
https://www.ncbi.nlm.nih.gov/pubmed/34510295
http://dx.doi.org/10.1007/s10067-021-05894-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782818/
https://www.ncbi.nlm.nih.gov/pubmed/34510295
http://dx.doi.org/10.1007/s10067-021-05894-2

Ejemplares similares